Application of urine proteome in diagnosis of schizophrenia patients
Urine proteins were analyzed through liquid chromatography tandem mass spectrometry technology, 35 differential proteins were screened out, and a kit was developed for diagnosing schizophrenia, which solved the problem of lack of effective biomarkers in the prior art and realized the application of urine proteomics in the diagnosis of schizophrenia.
CN119916026APending Publication Date: 2025-05-02BEIJING NORMAL UNIVERSITY +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CN202311418548.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-30
- Publication Date
- 2025-05-02
Smart Images
Figure BDA0004522757660000101 
Figure BDA0004522757660000111 
Figure BDA0004522757660000112
Abstract
The invention relates to application of urine proteome in diagnosis of schizophrenia patients. Specifically, the invention relates to application of a proteome identification reagent in preparation of a reagent for diagnosing schizophrenia in a subject, and the proteome is selected from one or more of proteins shown in a table 1 or a combination of the proteins.
Need to check novelty before this filing date? Find Prior Art